Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes

Peptides

Volumn 18, Issue 7, 1997, Pages 1009-1013

  Schiö, Helgi B ^a,d   Muceniece, Ruta ^a,b   Mutulis, Felikss ^a,b   Prusis, Peteris ^a   Lindeberg, Gunnar ^a   Sharma, Shubh D s ^c   Hiruby, Victor J ^c   Wikberg, Jarl E S ^a,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c UNIVERSITY OF ARIZONA   (United States)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

HS9510; Ligand binding; Melanocortin receptor subtypes; MSH; MTII; SHU9119

Indexed keywords

INTERMEDIN DERIVATIVE; RECEPTOR SUBTYPE;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; HORMONE RECEPTOR INTERACTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR BINDING;

ANIMALS; BINDING, COMPETITIVE; CLONING, MOLECULAR; COS CELLS; HUMANS; KINETICS; MELANOCYTE-STIMULATING HORMONES; PEPTIDES, CYCLIC; PROTEIN BINDING; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; TRANSFECTION;

ANIMALIA;

EID: 0030663516     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00079-X     Document Type: Article

References (26)

1. Al-Obeidi F., Castrucci A. L., Hadley M. E., Hruby V. J. Potent and prolonged acting cyclic lactam analogues of α-melanotropin Design based on molecular dynamics. J. Med. Chem. 32:1989;2555-2561.
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
3. Chhajlani V., Muceniece R., Wikberg J. E. S. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun. 195:1993;866-873.
4. Chhajlani V., Wikberg J. E. S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
5. Cody W. L., Wilkes B. C., Muska B. J., Hruby V. J., De L. Castrucci A. M., Hadley M. E. Cyclic melanotropins. 5 Importance of the C-terminal tripeptide (Lys-Pro-Val). J. Med. Chem. 27:1984;1186-1190.
6. Dorr R. T., Lines R., Levine N., Brooks C., Xiang L., Hruby V. J., Hadley M. E. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sciences. 58:1996;1777-1784.
7. Eberle, A. N. The melanotropins In: Chemistry, Physiology and Mechanisms of Action. Basel: S. Karger; 1988.
8. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S. J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J. Biol. Chem. 268:1993;8246-8250.
9. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S. J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J. Biol. Chem. 268:1993;15174-15179.
10. 10]melanotropin analogues. J. Med. Chem. 28:1983;125-129.
11. Haskell-Luevano C., Sawyer T. K., Trumpp-Kallmayer S., Bibber J. A., Humlet C., Gantz I., Hruby V. J. Three dimentional models of the hMC1R melanocortin receptor Complexes with melanotropin peptide agonists. Drug Design and Discovery. 14:1996;197-211.
12. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38:1995;3454-3461.
13. Hruby V. J., Wilkes B. C., Cody W. L., Sawyer T. K., Hadley M. E. Melanotropins Structural, conformational, and biological considerations in the development of superpotent and superprolonged analogs. Peptide Protein Rev. 3:1984;1-64.
14. Low, M. J.; Simerly, R. B.; Cone, R. D. Receptors for the melanocortin peptides in the central nervous system. Curr. Opin. Endocr. Diab. 79-88; 1994.
15. Mountjoy K. G., Robbins L. S., Mortrud M. T., Cone R. D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
16. O'Donahue T. L., Dorsa D. M. The opiomelanotropinergic neuronal and endocrine systems. Peptides. 3:1982;353-395.
17. Prusis P., Frändberg P. A., Muceniece R., Kalvinsh I., Wikberg J. E. S. A three dimentional model for the interaction of MSH with the melanocortin 1 receptor. Biochem. Biophys. Res. Commun. 210:1995;205-210.
18. Sahm U. G., Oliver G. W. J., Branch S. K., Moss S. H., Pouton C. W. Synthesis and biological evaluation of α-MSH analogues substituted with alanine. Peptides. 15:1994;1297-1302.
19. Sahm U. G., Qarawi M. A., Oliver G. W. J., Ahmed A. R. H., Branch S. K., Moss S. H., Pouton C. W. The melanocortin (MC3) receptor from rat hypothalamus photoaffinity labelling and binding of alanine-substituted α-MSH analogues. FEBS letters. 350:1994;29-32.
20. 10]-α-melanocyte stimulating hormone A cyclic α-melanotropin exibiting superagonist biological activity. Proc. Natl. Acad. Sci. USA. 79:1982;1751-1755.
21. 7]α-melanocyte stimulating hormone A highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. USA. 77:1980;5754-5758.
22. Schiöth H. B., Chhajlani V., Muceniece R., Klusa V., Wikberg J. E. S. Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors. Life Sciences. 59:1996;797-801.
23. Schiöth H. B., Kuusinen A., Muceniece R., Szardenings M., Keinänen K., Wikberg J. E. S. Expression of functional melanocortin 1 receptors in insect cells. Biochem. Biophys. Res. Commun. 221:1996;807-814.
24. Schiöth H. B., Muceniece R., Wikberg J. E. S. Characterisation of melanocortin 4 receptor by radioligand binding analysis. Pharmacol. Toxicol. 79:1996;161-165.
25. Schiöth H. B., Muceniece R., Wikberg J. E. S., Chhajlani V. Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur. J. Pharmacol. Mol. Pharm. Sect. 288:1995;311-317.
26. Simpson E. R., Waterman M. R. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Ann. Rev. Physiol. 50:1988;427-440.